SB INVESTMENT ADVISERS (UK) LTD

Holdings History for Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (RLAY)

Symbol: RLAY on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	2.4%	0%	$236,075,987	27,904,963	0		$8.46	Q4 2025
30 Sep 2025	1.1%	0%	$145,663,907	27,904,963	0		$5.22	Q3 2025
30 Jun 2025	0.77%	0%	$96,551,172	27,904,963	0		$3.46	Q2 2025
31 Mar 2025	0.67%	0%	$73,111,003	27,904,963	0		$2.62	Q1 2025
31 Dec 2024	1%	0%	$114,968,448	27,904,963	0		$4.12	Q4 2024
30 Sep 2024	1.6%	0%	$197,567,138	27,904,963	0		$7.08	Q3 2024
30 Jun 2024	1.7%	0%	$181,940,359	27,904,963	0		$6.52	Q2 2024
31 Mar 2024	2.3%	0%	$231,611,193	27,904,963	0		$8.30	Q1 2024
31 Dec 2023	2.7%	0%	$307,233,643	27,904,963	0		$11.01	Q4 2023
30 Sep 2023	1.9%	0%	$234,680,739	27,904,963	0		$8.41	Q3 2023
30 Jun 2023	2.7%	0%	$350,486,335	27,904,963	0		$12.56	Q2 2023
31 Mar 2023	3.8%	0%	$459,594,741	27,904,963	0		$16.47	Q1 2023
31 Dec 2022	3.5%	0%	$416,900,147	27,904,963	0		$14.94	Q4 2022
30 Sep 2022	4.8%	0%	$624,234,000	27,904,963	0		$22.37	Q3 2022
30 Jun 2022	3.7%	0%	$467,408,000	27,904,963	0		$16.75	Q2 2022
31 Mar 2022	4%	0%	$835,196,000	27,904,963	0		$29.93	Q1 2022
31 Dec 2021	2.5%	0%	$856,961,000	27,904,963	0		$30.71	Q4 2021
30 Sep 2021	2.7%	0%	$879,843,000	27,904,963	0		$31.53	Q3 2021
30 Jun 2021	2%	0%	$1,021,042,000	27,904,963	0		$36.59	Q2 2021
31 Mar 2021	1.7%	0%	$964,675,000	27,904,963	0		$34.57	Q1 2021
31 Dec 2020	4.7%	0%	$1,159,730,000	27,904,963	0		$41.56	Q4 2020
30 Sep 2020	10%	+10%	$1,188,472,000	27,904,963	+27,904,963	NEW	$42.59	Q3 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.